Is Human immunoglobulin proteins registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 6 valid registrations of Human immunoglobulin proteins, including PANZYGA (100 mg/ml, Solution for infusion, SAR 448.30).

Active substance

Human immunoglobulin proteins

SFDA 6

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
PANZYGA	100 mg/ml	Solution for infusion · Intravenous use	1 Vial	SAR 448.30	Biological · Prescription	OCTAPHARMA AG	Valid
PANZYGA	100 mg/ml	Solution for infusion · Intravenous use	1 Vial	SAR 1120.70	Biological · Prescription	OCTAPHARMA AG	Valid
PANZYGA	100 mg/ml	Solution for infusion · Intravenous use	1 Vial	SAR 2241.40	Biological · Prescription	OCTAPHARMA AG	Valid
PANZYGA	100 mg/ml	Solution for infusion · Intravenous use	1 Vial	SAR 13448.40	Biological · Prescription	OCTAPHARMA AG	Valid
PANZYGA	100 mg/ml	Solution for infusion · Intravenous use	1 Vial	SAR 8965.60	Biological · Prescription	OCTAPHARMA AG	Valid
PANZYGA	100 mg/ml	Solution for infusion · Intravenous use	1 Vial	SAR 4482.80	Biological · Prescription	OCTAPHARMA AG	Valid

Indications — CHI Daman Drug Formulary

OPTIC NEURITIS

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.